Home Supplements That Start With D Dan Shen Supplement: Cardiovascular Support, Antioxidant Power, Dosage, and Risks

Dan Shen Supplement: Cardiovascular Support, Antioxidant Power, Dosage, and Risks

August 29, 2025 Modified date: August 29, 2025

Dan Shen (Salvia miltiorrhiza), also called red sage or Chinese sage, is a traditional East Asian herb used for “blood stasis” syndromes—conditions related to circulation and chest discomfort in traditional medicine texts. Modern research has focused on heart and metabolic health, microcirculation, and, more recently, men’s urinary symptoms. Dan Shen’s root contains two broad classes of compounds: water-soluble phenolic acids (such as salvianolic acid B and danshensu) and fat-soluble tanshinones (such as tanshinone IIA). Together, they appear to affect oxidative stress, vascular tone, inflammation, platelet function, and lipid metabolism. This guide translates that science into clear, practical advice: where Dan Shen may help, where it does not, how to take it, and how to use it safely—especially if you take prescription medicines. You will also find dosage ranges from clinical studies and a concise safety checklist.

Essential insights for Dan Shen users

May improve cholesterol and triglycerides when added to statins; evidence for Dan Shen alone on lipids is weak.
Emerging data suggest benefits for male lower urinary tract symptoms at 400–800 mg extract daily.
Typical ranges: 400–800 mg standardized extract per day; traditional decoction 9–15 g dried root daily.
Avoid with warfarin and use extreme caution with other blood thinners due to bleeding risk.

What is Dan Shen?
Does Dan Shen work and for what?
How does Dan Shen work?
How to use Dan Shen
How much Dan Shen should I take?
Side effects and who should avoid

What is Dan Shen?

Dan Shen is the dried root and rhizome of Salvia miltiorrhiza Bunge, a mint-family plant native to China. It has a long record of use in traditional Chinese medicine (TCM) for problems characterized as “blood stasis,” including chest discomfort, menstrual irregularities, and circulation issues. In modern practice, Dan Shen is used both as a single herb and in combination formulas. One well-known proprietary formula is the Compound Danshen Dripping Pill; in hospitals, an injectable derivative (sodium tanshinone IIA sulfonate) is used as a prescription drug—not a supplement. This article focuses on oral supplements and teas rather than hospital-only injections.

What makes Dan Shen distinctive is its chemical diversity:

Phenolic acids (water-soluble): salvianolic acid B (also called Magnesium lithospermate B in salts), salvianolic acids A and C, and danshensu. These tend to exert antioxidant and endothelial effects and may influence lipid handling.
Tanshinones (fat-soluble): tanshinone IIA, cryptotanshinone, tanshinone I. These diterpenes often target inflammatory signaling, vascular smooth muscle, and drug-metabolizing enzymes.

Commercial products vary widely. Some extracts are standardized to salvianolic acid B or total phenolics; others to tanshinones; a few declare both. Powders and capsules made from simple dried root have a different profile than enriched extracts.

Regulatory status differs by region. In the European Union, regulators have not adopted a formal herbal monograph for Dan Shen due to inconsistent preparation descriptions and insufficient high-quality evidence for traditional or well-established medicinal use claims. This does not prohibit consumer sale everywhere, but it does signal that claims should stay conservative and that quality control matters.

In short, Dan Shen is not a miracle plant, but it is a pharmacologically rich root with plausible cardiovascular and metabolic actions. The rest of this guide explains what the best research suggests—and what it does not.

Does Dan Shen work and for what?

Lipids and metabolic markers (as an adjunct): The most encouraging human data are for lipid management when Dan Shen preparations are added to standard therapy (usually statins). A recent meta-analysis pooling dozens of trials reported additional improvements in total cholesterol, LDL, HDL, and triglycerides when Dan Shen compounds were used with statins compared with statins alone. That suggests Dan Shen may be a reasonable add-on for patients already under medical care, especially those still above lipid targets despite adherence. Importantly, most trials used combination therapy; very few tested Dan Shen as a stand-alone lipid-lowering agent. That distinction matters for expectations and for safety (see interactions).

Dan Shen alone for cardiovascular risk factors: A well-designed, placebo-controlled crossover trial in adults with hyperlipidemia and hypertension used a high-dose water extract for four weeks and found no meaningful benefit on blood pressure, endothelial function, coagulation markers, or inflammation. LDL cholesterol rose slightly compared with placebo. This study tempers expectations for Dan Shen as monotherapy on traditional cardiometabolic risk factors, at least over short treatment windows.

Men’s urinary symptoms (LUTS/BPH): A multicenter, randomized, double-blind, placebo-controlled trial evaluated a standardized Salvia miltiorrhiza root extract (400 or 800 mg daily) for 12 weeks in men with lower urinary tract symptoms. Results showed improvements in symptom scores and erectile function measures without significant safety concerns, particularly at 400 mg per day. This is a new and promising area but requires replication and longer follow-up to confirm durability and effects on objective measures such as flow rate or residual volume.

Circulation and microvascular comfort: Many traditional uses—cold hands and feet, feelings of chest tightness, or menstrual discomfort—map to microcirculatory changes and platelet activity. Preclinical and small clinical studies suggest Dan Shen compounds can influence endothelial function and platelet aggregation. However, outcomes like fewer heart attacks or strokes have not been established for oral supplements, and several trials are small, open-label, or use multi-herb formulas where Dan Shen’s specific contribution is unclear.

Bottom line:

Strongest human signal: adjunctive lipid improvements when combined with statins.
Emerging but preliminary: male LUTS improvements with 400–800 mg/day extract over 12 weeks.
Weak or negative: short-term monotherapy for traditional cardiometabolic risk markers.
Not established: hard outcomes (heart attack, stroke prevention) with over-the-counter oral Dan Shen.

As with most botanicals, product quality, preparation (water vs ethanol extracts), and standardization to specific markers can explain why results vary. For practical use, consider Dan Shen as a supportive adjunct under clinician oversight rather than a replacement for guideline-directed care.

How does Dan Shen work?

Dan Shen’s actions arise from multiple compound families that act on complementary targets in the cardiovascular and metabolic network.

Antioxidant and endothelial support (phenolic acids): Salvianolic acids and danshensu are potent polyphenols that help quench reactive oxygen species and support nitric-oxide-mediated vasodilation. In endothelial cells, they have been shown to modulate PI3K/Akt and JAK/STAT pathways and to reduce expression of adhesion molecules that recruit inflammatory cells to vessel walls. These pathways align with observed improvements in lipid profiles when Dan Shen is added to statins and suggest a role in limiting LDL oxidation and vascular inflammation.

Anti-inflammatory and smooth muscle effects (tanshinones): Lipophilic tanshinones, especially tanshinone IIA, influence NF-κB and MAPK signaling and can relax vascular smooth muscle. They also interact with PPAR-alpha, a regulator of fatty acid oxidation, providing a plausible mechanism for triglyceride and HDL effects. Tanshinone IIA has been examined for broader vascular protection in preclinical models, but translating these effects to clinical endpoints requires more and better trials.

Platelet and coagulation modulation: Extracts of Dan Shen and specific constituents can inhibit platelet aggregation, interfere with parts of the clotting cascade, and promote fibrinolysis in experimental systems. These properties are a double-edged sword: they may help microcirculation yet increase bleeding risk when combined with anticoagulants or antiplatelet drugs.

Lipid metabolism and HMG-CoA reductase: Network analyses and docking studies suggest some Dan Shen compounds act as class II inhibitors of HMG-CoA reductase (the statin target) and upregulate LDL receptors via PPAR-alpha pathways. While intriguing, these in silico and exploratory findings should be read as hypothesis-generating until confirmed by rigorous pharmacodynamic studies in humans.

Drug-metabolizing enzymes: Tanshinones may modulate cytochrome P450 activity—most notably CYP3A4—in vitro. The clinical significance varies by preparation, dose, and co-medications. Water-based products tend to contain more phenolic acids; ethanol extracts concentrate tanshinones. This is one reason product choice and medical supervision matter in patients on narrow-therapeutic-index drugs.

Takeaway: Dan Shen is best understood as a multimodal vascular-metabolic modulator that can complement standard therapy through antioxidant, anti-inflammatory, endothelial, lipid, and platelet pathways. Those same mechanisms explain both potential benefits and its most important safety cautions (interactions and bleeding).

How to use Dan Shen

1) Match the goal to the preparation

Adjunct to lipid therapy: Prefer standardized extracts that declare marker content (e.g., % salvianolic acids and/or tanshinones). Most of the add-on lipid trials used defined preparations rather than raw powder alone.
Men’s urinary symptoms: In the positive randomized trial, men used 400 mg/day of a standardized Salvia miltiorrhiza extract (some also received 800 mg/day). If LUTS is your main concern, aim for a product that resembles the research extract.
Traditional uses (tea/decoction): Practitioners often use 9–15 g dried root in decoction formulas (see dosage section). Teas deliver more phenolic acids and fewer tanshinones compared with alcohol extracts.

2) Start low, go slow

Begin at the lower end of the relevant range for your goal and titrate after 1–2 weeks if needed. Splitting the dose twice daily is common. If you take any prescription anticoagulant or antiplatelet, do not start Dan Shen without medical advice.

3) Time with meals for comfort

Dan Shen is generally well tolerated. Taking it with food may reduce occasional stomach upset in sensitive users. Because of theoretical interactions, avoid taking it at the exact same time as medications with a narrow therapeutic index; separate by a few hours if your clinician agrees.

4) Combine thoughtfully

With statins: The most robust signal is as a statin add-on. Work with your prescriber to monitor lipids and liver enzymes as usual.
With other botanicals: Avoid stacking Dan Shen with other herbs that affect clotting (e.g., high-dose garlic, ginkgo) unless a clinician directs it.
With antihypertensives: If you run low-normal blood pressure, monitor for dizziness on standing as you add new supplements.

5) Monitor outcomes

Track objective markers every 8–12 weeks (lipid panel for cardiometabolic goals; symptom scores for LUTS like the International Prostate Symptom Score). If you do not see benefit by three months, reconsider the plan with your clinician.

6) Choose quality

Look for brands that disclose standardization, publish third-party testing (identity, potency, heavy metals, pesticides, and microbial limits), and batch numbers. Because Dan Shen grows in soils where metals can accumulate, quality control is not optional. Prefer suppliers who specify Salvia miltiorrhiza (not substitutes) and identify the plant part as root/rhizome.

7) Know what Dan Shen is not

Oral Dan Shen supplements are not a substitute for statins, ACE inhibitors, or other evidence-based medicines in high-risk patients. Hospital-grade injections (e.g., sodium tanshinone IIA sulfonate) are a different category and should not be self-administered.

How much Dan Shen should I take?

Standardized extracts (capsules/tablets)

Common range: 400–800 mg per day, often divided (e.g., 200–400 mg twice daily).
Context: In a multicenter, placebo-controlled trial for male lower urinary tract symptoms, 400 mg/day of a standardized root extract improved symptom scores with favorable tolerability over 12 weeks; 800 mg/day was also tested. If you aim to mirror those results, match dose, duration, and product type as closely as possible.

Traditional decoction (tea)

Typical range: 9–15 g dried root per day in decoction. This range reflects classical and modern pharmacopoeia guidance and has been used as the reference for dosing equivalency in clinical trials. For example, a trial that used 3 g of a 5:1 water extract noted this equates to 15 g of raw root. In practice, decoctions are commonly combined with other herbs; if used alone, start at the low end and monitor tolerability.

Combination products

Proprietary formulas such as Compound Danshen Dripping Pill have manufacturer-specific dosing and often include additional herbs like notoginseng and borneol. While studied in China and used clinically there, these are not the same as single-herb Dan Shen and may have different interaction profiles. They should be used under clinician supervision, especially with anticoagulants.

Timing and duration

When to take: With meals if you experience stomach upset; otherwise, morning and evening are common.
How long: Reassess at 8–12 weeks. If you see benefit and tolerate it, many continue for 3–6 months with periodic breaks while tracking labs or symptom scores.
When to stop: Discontinue and seek care if you notice easy bruising, nosebleeds, black stools, persistent dizziness, or any sign of bleeding.

Special populations

Older adults: Begin at the lower end (e.g., 200–400 mg/day extract).
Liver or kidney disease: Use only with medical supervision and clear monitoring; adjustments may be required or use avoided.
Pregnancy and lactation: Avoid due to insufficient safety data.

Practical note on standardization
If a label lists both salvianolic acids and tanshinones, the product is attempting a broad-spectrum profile. If it lists only one marker, do not assume equivalence to studies that used the other. Inconsistent standardization is one reason results differ, and it is also why the same milligram amount from two brands may not be functionally comparable. When possible, choose products whose dose and composition reasonably match those used in clinical research most relevant to your goal.

Side effects and who should avoid

Common tolerability
Most people tolerate oral Dan Shen well at typical doses. Mild stomach upset, dry mouth, headache, or dizziness can occur and usually resolve with dose adjustment or taking with food. Skin rash is uncommon but possible; discontinue if it appears.

Bleeding and anticoagulants: the key caution
Dan Shen can inhibit platelet aggregation and affect coagulation pathways. The most important, well-documented interaction is with warfarin. Case reports and pharmacokinetic studies indicate that Dan Shen can potentiate warfarin’s effect, raising INR and bleeding risk. Newer research examining compound Dan Shen formulas suggests gene-dependent modulation of warfarin pharmacodynamics (e.g., epoxide hydrolase variants), but from a practical safety standpoint, the conservative advice remains: do not combine Dan Shen with warfarin unless a specialist directs and closely monitors you.

Because Dan Shen can affect platelet function, be cautious with:

Antiplatelets (aspirin, clopidogrel, prasugrel, ticagrelor).
Direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban).
Herbs/supplements that also influence clotting (e.g., high-dose garlic, ginkgo).

If your clinician approves Dan Shen with any blood-thinning therapy, monitor for bruising, gum bleeding, black stools, or prolonged bleeding from cuts and obtain regular labs as advised.

Drug-metabolizing enzymes (CYPs)
Tanshinones may inhibit or induce CYP3A4 in vitro, raising theoretical interaction potential with medications such as certain statins, calcium channel blockers, and immunosuppressants. The clinical significance depends on the specific preparation and dose. To reduce risk:

Prefer water-based or balanced extracts if you take multiple CYP3A4-substrate medicines.
Space dosing away from critical medications when feasible.
Involve your pharmacist or clinician to check for known interactions.

Blood pressure and glucose
Dan Shen is unlikely to cause large blood pressure drops, but additive effects with antihypertensives are possible. Rarely, people report lightheadedness on standing. Limited data suggest neutral effects on blood glucose at common doses; those on hypoglycemics should still monitor as usual when adding any new supplement.

Surgery and dental procedures
Because of antiplatelet effects, stop Dan Shen 7–10 days before elective surgery or invasive dental work unless your surgeon advises otherwise.

Who should avoid Dan Shen

Pregnant or breastfeeding individuals (safety data are insufficient).
People on warfarin (unless under specialist supervision with frequent INR monitoring).
Those with active bleeding, bleeding disorders, peptic ulcer with recent bleeding, or very low platelet counts.
Pre-operative patients not yet cleared to continue supplements.
Individuals with complex polypharmacy involving narrow-therapeutic-index CYP3A4 substrates, unless a clinician reviews all interactions.

When to seek medical help
Seek prompt care for signs of internal bleeding (black or tarry stools, vomiting blood or coffee-ground material), severe dizziness or fainting, chest pain, shortness of breath, or any allergic reaction (swelling of lips/tongue, wheeze, hives).

Regulatory context
In the EU, regulators concluded that available data and product descriptions were too inconsistent to establish a formal monograph for Dan Shen preparations. This does not resolve individual product safety but underscores the need for brand diligence and clinician involvement when combining Dan Shen with prescription therapy.

References

Medical disclaimer and a small request

This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Always speak with a qualified healthcare professional before starting, stopping, or combining any supplement with prescription medicines—especially blood thinners or drugs with a narrow therapeutic range.

If you found this guide useful, please consider sharing it with a friend or on your favorite platform (Facebook, X, or anywhere you connect). Your support helps us keep producing clear, trustworthy health content. Thank you.